US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 20.120
- -2.910-12.64%
Close Jul 19 16:00 ET
- 20.500
- +0.380+1.89%
Post 18:33 ET
735.92MMarket Cap-13875P/E (TTM)
24.020High19.610Low229.48KVolume23.510Open23.030Pre Close4.82MTurnover2.49%Turnover RatioLossP/E (Static)36.58MShares28.08052wk High-18.56P/B185.10MFloat Cap18.00052wk Low--Dividend TTM9.20MShs Float28.080Historical High--Div YieldTTM19.15%Amplitude18.000Historical Low21.006Avg Price1Lot Size
Rapport Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|
| Total revenue | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 |
| Cost of revenue | |||
| Gross profit | |||
| Operating expense | 229.30%17.09M | 36.18M | 5.19M |
| Selling and administrative expenses | 255.26%4.59M | --8.18M | --1.29M |
| -General and administrative expense | 255.26%4.59M | --8.18M | --1.29M |
| Research and development costs | 220.70%12.5M | --28M | --3.9M |
| Operating profit | -229.30%-17.09M | -36.18M | -5.19M |
| Net non-operating interest income expense | 2,320.00%1.82M | 2.53M | 75K |
| Non-operating interest income | 2,320.00%1.82M | --2.53M | --75K |
| Non-operating interest expense | ---- | --0 | ---- |
| Other net income (expense) | -617.48%-7.39M | -1.12M | -1.03M |
| Gain on sale of security | -617.48%-7.39M | ---1.12M | ---1.03M |
| Income before tax | -268.84%-22.67M | -34.78M | -6.15M |
| Income tax | 0 | 10K | 1K |
| Net income | -268.78%-22.67M | -34.79M | -6.15M |
| Net income continuous Operations | -268.78%-22.67M | ---34.79M | ---6.15M |
| Minority interest income | |||
| Net income attributable to the parent company | -268.78%-22.67M | -34.79M | -6.15M |
| Preferred stock dividends | |||
| Other preferred stock dividends | |||
| Net income attributable to common stockholders | -268.78%-22.67M | -34.79M | -6.15M |
| Basic earnings per share | -269.97%-0.94 | -1.47 | -0.2541 |
| Diluted earnings per share | -269.97%-0.94 | -1.47 | -0.2541 |
| Dividend per share | |||
| Currency Unit | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
